Note 13 - Revenue From Contracts with Customers (Tables)

12 Months Ended

Sep. 30, 2024

Notes Tables

Disaggregation of Revenue [Table Text Block]

	2024		2023		2022
Significant Business Line
Multiomics	$	254,552	$	248,296	$	250,937
Core Products(1)		196,732		192,061		199,230
Sample Repository Services		121,914		111,593		105,331
B Medical Systems		83,125		113,122		-
Total revenue	$	656,323	$	665,072	$	555,498

Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]

	As of September 30, 2024
	Less than 1 Year		Greater than 1 Year		Total
Remaining performance obligations	$	92,130	$	29,581	$	121,711